• PDF / 168,924 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 28 Downloads / 242 Views

DOWNLOAD

REPORT

---

1 S

Febrile neutropenia: case report In a retrospective study of 339 patients, a patient [age and sex not stated] was described, who developed febrile neutropenia during adjuvant chemotherapy with paclitaxel and cyclophosphamide for breast cancer. The patient, who was diagnosed with breast cancer, started receiving adjuvant chemotherapy with paclitaxel and cyclophosphamide [routes and dosages not stated]. During the first cycle, the patient developed febrile neutropenia [durations of treatments to reaction onset and outcome not stated]. Chantharakhit C, et al. Pretreatment absolute Neutrophil-to-Lymphocyte ratio (NLR) predict the risk for febrile neutropenia in the first cycle adjuvant chemotherapy for breast 803519680 cancer. Asia Pacific Journal of Cancer Biology 5: 81-87, No. 3, 2020. Available from: URL: http://doi.org/10.31557/APJCB.2020.5.3.81-87

0114-9954/20/1833-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 5 Dec 2020 No. 1833